Free Content Dose-dependent effect of dobutamine on chemoreflex activity in healthy volunteers

Authors: Pathak, Atul; Velez-Roa, Sonia; Xhaët, Olivier; Najem, Boutaina; van de Borne, Philippe

Source: British Journal of Clinical Pharmacology, Volume 62, Number 3, September 2006 , pp. 272-279(8)

Publisher: Blackwell Publishing

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Abstract:

Aims 

β-adrenergic agonists increase peripheral chemoreceptor sensitivity in humans. We tested the hypothesis that β1-agonist-related increase in peripheral chemoreflex sensitivity is selective and dose-dependent. Methods 

Using a double-blind, placebo-controlled, randomized, crossover study, we examined the effects of dobutamine (n = 17 healthy subjects) at perfusion rates of 2.5 µg kg−1 min−1 (D2.5) and 7.5 µg kg−1 min−1 (D7.5) on ventilation, haemodynamics and sympathetic nerve activity during normoxia, isocapnic hypoxia, posthypoxic maximal voluntary end-expiratory apnoea, hyperoxic hypercapnia and cold pressor test (CPT). We analysed the effect of pretreatment with atenolol on dobutamine-evoked chemosensitivity. Results 

Dobutamine dose-dependently increased ventilation (placebo 6.7 ± 0.5 vs. D2.5 7.8 ± 0.4 vs. D7.5 8.7 ± 0.4 l min−1, P < 0.005) during normoxia, enhanced the ventilatory (placebo 14.4 ± 0.6 vs. D2.5 17.3 ± 0.8 vs. D7.5 22.5 ± 1.9 l min−1, P < 0.0001) and sympathetic (placebo + 215 ± 31 vs. D2.5 + 285 ± 19 vs. D7.5 + 395 ± 50% of baseline, P < 0.03) responses at the fifth minute of isocapnic hypoxia and enhanced the sympathetic response to apnoea performed after hypoxia (increase after 5 min of hypoxia: + 290 ± 43% for placebo vs.+ 360 ± 21% for D2.5 vs. 537 ± 69% for D7.5, P < 0.05). No differences were observed between dobutamine and placebo in the responses to hyperoxic hypercapnia and CPT. Atenolol inhibited the dobutamine-related hyperventilation and apnoea shortening during normoxia and hypoxia. Conclusion 

Dobutamine enhances peripheral chemosensitivity at low infusion rates selectively and in a dose-dependent manner. There is a β1 adrenoceptor component in dobutamine-evoked increase in peripheral chemosensititivity; however, a contribution of additional adrenoceptor subtypes cannot be excluded.

Keywords: chemoreflex; dobutamine; pharmacology

Document Type: Research article

DOI: 10.1111/j.1365-2125.2006.02657.x

You have access to the full text article on a website external to Ingentaconnect.

Please click here to view this article on InterScience.

You may be required to register and activate access on InterScience before you can obtain the full text. If you have any queries please contact onlinehelp@oxon.blackwellpublishing.com

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A